|
Winner of the 10 Million Dollar Export Tower Award
2015.12.07
|
|---|
|
- Daehan New Pharm Wins the “10 Million Dollar Export Tower” at the 52nd Trade Day - CEO Bae Gun-Woo Receives Commendation from the Minister of Trade, Industry and Energy
Daehan New Pharm is a mid-sized pharmaceutical company specialized in the fields of wellness and chronic disease treatment, focusing on professional pharmaceuticals, veterinary medicines, stem cell technology, and bio-process materials. Through specialization, concentration, and globalization of its core businesses, the company currently generates about 15% of its total performance from overseas markets.
Unlike most domestic pharmaceutical companies that mainly export raw materials, Daehan New Pharm has built its presence through exports of finished pharmaceutical products to China, Russia, and Southeast Asia, while also pioneering new markets such as Cuba. By actively targeting emerging economies, the company has expanded its global presence to over 20 countries and nurtured partnerships with more than 60 strategic partners, successfully establishing a worldwide network. This achievement carries great significance as a growth model for mid-sized pharmaceutical firms.
Global expansion has not only strengthened Daehan New Pharm’s growth momentum through overseas market development but has also elevated its overall management capabilities. The company’s commitment to global-level quality management, internationally trusted branding, and its success in challenging environments have instilled a strong spirit of challenge and confidence among employees—an invaluable asset beyond the tangible achievement of ten million dollars in exports. This organizational drive has enabled Daehan New Pharm to double its size over the past five years and build sustainable growth capabilities exceeding 20%. The company aims to increase the proportion of overseas business from 15% to over 20% by 2020, advancing beyond export-based globalization toward deeper strategic alliances and direct international expansion. In addition, CEO Bae Gun-Woo was awarded the Minister of Trade, Industry and Energy Commendation in recognition of his leadership and outstanding contribution to expanding finished pharmaceutical exports. Since his appointment in 2008, he has doubled the company’s export volume—from 5.83 million dollars to over 10 million dollars—achieving remarkable export growth and transforming Daehan New Pharm into a globally competitive pharmaceutical exporter. |


Home